Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares are trading higher Wednesday following a recent corporate presentation.
What To Know: During the presentation, the company provided peak sales estimates for drugs in its portfolio.
Additionally, Mizuho analyst Graig Suvannavejh reiterated Axsome Therapeutics with a Buy and maintained the $95 price target.
Earlier this week, Morgan Stanley analyst Vikram Purohit maintained Axsome Therapeutics with a Equal-Weight and raised the price target from $87 to $90.
Related Link: Why Allogene Stock Is Trading Down Today
AXSM Price Action: Shares of AXSM were up 8.63% at $81.34 at the time of publication, according to Benzinga Pro.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
